Who
Milos Miljkovic
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Cartesian Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $988K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Nov 2023
- Last trade
- 6 Jan 2026
- Last filed
- 8 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jan 2026filed 8 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K3,573 at $6.82 | filing |
| 6 Jan 2026filed 8 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K3,573 at $6.82 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 6 Jan 2025filed 7 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $16K948 at $16.83 | filing |
| 3 Jan 2025filed 7 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $16K932 at $16.72 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —56,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 15 Nov 2024filed 18 Nov 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 | filing |
| 15 Nov 2024filed 18 Nov 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $65K20,000 at $3.23 | filing |
| 15 Nov 2024filed 18 Nov 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $343K20,000 at $17.14 | filing |
| 14 Nov 2024filed 18 Nov 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —35,000 | filing |
| 14 Nov 2024filed 18 Nov 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code M | $113K35,000 at $3.23 | filing |
| 14 Nov 2024filed 18 Nov 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Sold | $565K35,000 at $16.13 | filing |
| 8 Apr 2024filed 10 Apr 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,565.87 | filing |
| 8 Apr 2024filed 10 Apr 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —85,528 | filing |
| 2 Jan 2024filed 4 Jan 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —703,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —548,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.